Lantheus price target raised to $89 from $82 at Truist

Truist raised the firm’s price target on Lantheus (LNTH) to $89 from $82 and keeps a Buy rating on the shares. The company posted a PYLARIFY-driven Q4 EPS beat and an expected below-consensus 2026 guide, with benefits from key upcoming product approvals left as upside, the analyst tells investors in a research note. Truist adds it sees compelling growth re-acceleration prospects in the second half of the year and a return to the double-digit growth in FY27.